Literature DB >> 15194774

The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Sarah E Blutt1, Sue E Crawford, Kelly L Warfield, Dorothy E Lewis, Mary K Estes, Margaret E Conner.   

Abstract

The early response to a homologous rotavirus infection in mice includes a T-cell-independent increase in the number of activated B lymphocytes in the Peyer's patches. The mechanism of this activation has not been previously determined. Since rotavirus has a repetitively arranged triple-layered capsid and repetitively arranged antigens can induce activation of B cells, one or more of the capsid proteins could be responsible for the initial activation of B cells during infection. To address this question, we assessed the ability of rotavirus and virus-like particles to induce B-cell activation in vivo and in vitro. Using infectious rotavirus, inactivated rotavirus, noninfectious but replication-competent virus, and virus-like particles, we determined that neither infectivity nor RNA was necessary for B-cell activation but the presence of the rotavirus outer capsid protein, VP7, was sufficient for murine B-cell activation. Preincubation of the virus with neutralizing VP7 antibodies inhibited B-cell activation. Polymyxin B treatment and boiling of the virus preparation were performed, which ruled out possible lipopolysaccharide contamination as the source of activation and confirmed that the structural conformation of VP7 is important for B-cell activation. These findings indicate that the structure and conformation of the outer capsid protein, VP7, initiate intestinal B-cell activation during rotavirus infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194774      PMCID: PMC421650          DOI: 10.1128/JVI.78.13.6974-6981.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  Studies on B-cell activation in vitro.

Authors:  F Melchers; C Corbel
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

2.  Heterogeneity in the structural glycoprotein (VP7) of simian rotavirus SA11.

Authors:  M K Estes; D Y Graham; R F Ramig; B L Ericson
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

3.  Regulation of human B-cell activation, proliferation, and differentiation by soluble factors.

Authors:  A Muraguchi; J H Kehrl; J L Butler; A S Fauci
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

4.  Antigenic comparisons of two new rotaviruses from rhesus monkeys.

Authors:  G Stuker; L S Oshiro; N J Schmidt
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

5.  Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.

Authors:  D M Lopez; V Charyulu; M M Sigel
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

6.  Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus.

Authors:  J P Coutelier; J Van Snick
Journal:  Eur J Immunol       Date:  1985-03       Impact factor: 5.532

7.  Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies.

Authors:  H Greenberg; V McAuliffe; J Valdesuso; R Wyatt; J Flores; A Kalica; Y Hoshino; N Singh
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

9.  Sendai virus glycoproteins are T cell-dependent B cell mitogens.

Authors:  S Kizaka; G Goodman-Snitkoff; J J McSharry
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  17 in total

Review 1.  The isolator piglet: a model for studying the development of adaptive immunity.

Authors:  J E Butler; Marek Sinkora
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice.

Authors:  Geoffrey A Preidis; Delphine M Saulnier; Sarah E Blutt; Toni-Ann Mistretta; Kevin P Riehle; Angela M Major; Susan F Venable; James P Barrish; Milton J Finegold; Joseph F Petrosino; Richard L Guerrant; Margaret E Conner; James Versalovic
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

3.  Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model.

Authors:  Kelly L Warfield; Sarah E Blutt; Sue E Crawford; Gagandeep Kang; Margaret E Conner
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

4.  Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model.

Authors:  Ana M González; Marli S P Azevedo; Kwonil Jung; Anastasia Vlasova; Wei Zhang; Linda J Saif
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

5.  Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

Authors:  Cristina L Swanson; Timothy J Wilson; Pamela Strauch; Marco Colonna; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

6.  Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.

Authors:  Whitney E Purtha; Karen A Chachu; Herbert W Virgin; Michael S Diamond
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

7.  C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Dan Liao; Uddalak Bharadwaj; Min Li; Qizhi Yao; Changyi Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-20       Impact factor: 8.311

8.  Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease.

Authors:  F Ziberna; G De Lorenzo; V Schiavon; F Arnoldi; S Quaglia; L De Leo; S Vatta; S Martelossi; O R Burrone; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2016-09-29       Impact factor: 4.330

Review 9.  Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species.

Authors:  Anastasia N Vlasova; Sukumar Kandasamy; Kuldeep S Chattha; Gireesh Rajashekara; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2016-01-14       Impact factor: 2.046

10.  Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.

Authors:  Emily M Deal; Katharina Lahl; Carlos F Narváez; Eugene C Butcher; Harry B Greenberg
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.